While it's not as necessary on newer hardware, old and less capable desktops or laptops could get a helpful boost from any ...
Zenocutuzumab--zbco, marketed as BIZENGRI (R), received Breakthrough Therapy Designation from the FDA in October 2025 and was granted accelerated approval in December 2024 for adults with advanced ...
(a) Non-GAAP financial information is adjusted to an effective tax rate of 18% in the three months and year ended December 31, 2025 and 17% in the three months and year ended 2024 on a non-GAAP basis, ...